The Republic of Ireland is to resume administering the Oxford-AstraZeneca vaccine this weekend.
The country's National Immunisation Advisory Committee (NIAC) recommended the move after an review by The European Medicines Agency (EMA).
It follows a temporary suspension of the vaccine in Ireland after reports of blood clotting in adults in Norway.
On Friday, 10 more Covid-19 related deaths were reported in the Republic, taking its death toll to 4,576.
A further 507 cases of the virus were also recorded, bringing the total number of confirmed cases to 229,306.
There are currently 336 Covid-19 patients in hospitals in the Republic, of which 87 are in ICU.
UK and EU regulators conducted a "thorough and careful review" of all blood clotting events occurring with the Oxford-AstraZeneca vaccine to determine if there is a possible safety risk.
On Thursday, the EMA concluded that the benefits of the vaccine in combating the threat of Covid-19 "continue to outweigh the risk of side effects".
More than 117,000 doses of the Oxford-AstraZeneca vaccine have been administered in the Republic of Ireland.
Ireland's Health Minister Stephen Donnelly said administration of the vaccine will resume this weekend.
Good news on the restarting of AstraZeneca. The HSE is this evening updating clinicians and the information leaflet and will be administering the vaccine this weekend, as well as the already planned vaccination activity. pic.twitter.com/vg3LiClW9R— Stephen Donnelly (@DonnellyStephen) March 19, 2021